|Previous Section||Index||Home Page|
Norman Lamb: To ask the Secretary of State for Health how many patients in each hospital trust had their discharge from hospital delayed in each week (a) in the last 12 months and (b) in the preceding 12 months. 
Norman Lamb: To ask the Secretary of State for Health how many bed nights in each hospital trust were spent by patients who were ready for discharge but remained in hospital in (a) the last 12 months and (b) the preceding 12 months; and what the estimated total cost to the NHS was of these delayed discharges. 
Ann Keen: No specific date has been set for either the commencement or completion of the deep-clean programme. The delivery of this programme is entirely a matter for local determination and will be affected by a range of local factors and considerations including, but not limited to, the size, age and configuration of the hospital and the extent of the deep-cleaning necessary. It is not therefore possible to provide any estimated average of either the cost or the length of time it will take. The funding for this programme will be allocated by individual strategic health authorities.
Ann Keen: In the studies conducted in 1980 and 1993-94, hospital acquired infection was defined as an infection found to be active, or under active treatment at the time of the survey, which was not present on admission to hospital(1, 2).
The definition for health care associated infection (HCAI) used in the 2006 survey was the one devised by the Centres for Disease Control and Prevention, Atlanta, United States America, that is, any infection reported must meet the definition of a HCAI, that is, a local or systemic condition resulting from adverse reaction to the presence of an infectious agent(s) or its toxins. There must be no evidence that it was present or incubating at the time of hospital admission unless the infection was related to a previous admission to the same hospital (i.e. the hospital under surveillance.)(3)
(1) Meers PD, Ayliffe GA, Emmerson AM et al. Report on the national prevalence survey of infection in hospitals 1980. J Hosp Infect 1981; s1-51.
(2) Report of a steering group. National prevalence survey of hospital-acquired infections: definitions. J Hosp Infect 1993; 24:69-76.
Mr. Lansley: To ask the Secretary of State for Health if he will place in the Library the data collected from each of the 190 acute hospitals which were surveyed as part of the Third Prevalence Survey of Healthcare Associated Infections in Acute Hospitals in England 2006, published by his Department on 12 September 2007. 
Ann Keen: Participation in the Third Prevalence Survey of Healthcare Associated Infections in acute hospitals in England 2006 was voluntary and as the national data was anonymised, we do not have individual trusts data. Trusts who participated in the survey can access their own data via a secure web-based system developed by the Welsh Healthcare Associated Infection Programme.
Mr. Burstow: To ask the Secretary of State for Health what steps his Department has taken to ensure that NHS hospital food meets acceptable nutritional standards, with particular reference to elderly patients; and if he will make a statement. 
Ann Keen: An appropriate diet, based on acceptable standards, requires good food with the right nutritional content, properly prepared and available when patients need it. The National Health Service Plan stipulated that dieticians should advise and check on nutritional values in hospital food. Nutritional information is available for all recipes in the National Dish Selector, and this can be used to assess local nutritional levels. Ingredients specifications for the recipes have been developed by the Purchasing and Supply Agency to ensure that wholesome, high quality and value-for-money ingredients are used.
The Food Standards Agency (FSA) Strategic Plan for 2005-10 includes a commitment to support other Government Departments to set targets to improve the nutritional quality of meals served in major institutions. Work is under way to develop nutrient and
food based guidance for institutions that will support cross-Government action on diet and food procurement. The first set of guidance, including an example menu, for those providing food to older people in residential care who do not have specific diet-related medical needs, was published by the FSA in October 2006. Guidance for institutions providing food to adults who do not have specific diet-related medical needs, will be published before the end of October 2007.
The quality of hospital food is measured annually via Patient Environment Action Team (PEAT) assessments. These showed an increase from 17 per cent. good in 2002 to 32 per cent. excellent in 2006 (there was no excellent category in 2002, when a three-point scale was used).
Older people in hospital may prefer to eat little and often, and this was provided for in the NHS Plan. For the last year in which statistics were collected, (2004) 89 per cent. of hospitals had introduced ward kitchen services to provide light snacks, 80 per cent. were providing snack boxes for patients who missed a meal and 84 per cent. provided extra snacks during the day.
It is known that older people in hospital are vulnerable to malnutrition. To identify and deal with patients at risk, we have introduced protected mealtimes and have renewed the emphasis on nutritional screening. These two areas of work are being actively pursued by the National Patient Safety Agency.
A national action plan to tackle the issue of older people and nutrition more generally was announced on 14 March 2007 by my hon. Friend the Under-Secretary of State for Health (Mr. Lewis). The action plan followed a nutrition summit on the same day, attended by leading charities, clinicians, nutrition experts and care home representatives. It will be published in November 2007 and will outline a range of measures that NHS and social care managers can take to address nutrition, hydration and nutritional care issues in all settings. FSA guidance to improve meals served in major institutions contributes to this national action plan.
Dawn Primarolo: The Secretary of State for Health and other departmental Ministers all make regular visits to national health service and social care facilities, including hospitals, general practitioner practices and primary and community services.
Kingston Hospital, Surrey
Kings College, London
The Princess Alexandra Hospital, Hamstell Road, Harlow, Essex
Musgrove Park Hospital, Taunton, Somerset
Great Ormond Street Hospital, London
Royal Marsden, London
Essex Cardiothoracic Centre, Basildon, Essex
Queen Elizabeth Hospital, Birmingham
St. Georges Hospital, London
Royal Exeter and Devon
Tiverton District Hospital, Tiverton, Devon
St. Peters HospChertsey
Leeds General Infirmary
St. James Hospital, Leeds
Hammersmith Hospital, London
Charing Cross Hospital, London
Royal Liverpool University Hospital
Peasley Cross Hospital, St. Helens
Gateshead Healthcare NHS Foundation Trust (FT), Gateshead
University Hospital of South Manchester NHS FT, Manchester
York Hospital NHS FT, York
City Hospital, Birmingham
Derby Royal Infirmary, Derby
Princess Alexandra Hospital, Harlow, Essex
St. Margarets Community Hospital, Epping, Essex
Basingstoke and North Hampshire Hospitals NHS FT, Basingstoke
Conquest Hospital, St. Leonards-on-Sea, East Sussex
West View Hospital Plummer Lane, Tenterden, Kent
Tiverton District Hospital, Tiverton, Devon
Royal Devon and Exeter NHS Foundation Trust, Exeter
Mrs. May: To ask the Secretary of State for Health if he will publish, in full, the recommendations of the Joint Committee on Vaccination and Immunisation on the human papilloma virus (HPV) vaccination programme before its next meeting in February; what plans he has to introduce an HPV programme for girls aged 12 to 13; what plans he has to extend an HPV programme to young women older than 13; and if he will make a statement. 
Dawn Primarolo: On 26 October, my right hon. Friend the Secretary of State (Alan Johnson) announced the introduction of a human papilloma virus (HPV) immunisation programme to routinely vaccinate girls aged 12-13 years of age against cervical cancer, starting from September 2008.
Mr. Drew: To ask the Secretary of State for Health what the names, qualifications and responsibilities are of those on the Expert Group set up to reclassify continence and stoma prescription products. 
Mr. Drew: To ask the Secretary of State for Health for what reason two options were provided under Part IX of the Drug Tariff for the reclassification of continence products according to the proposed reimbursement price reduction model. 
Mr. Drew: To ask the Secretary of State for Health what assessment he has made of the likely impact on services to patients if drug companies adopt option 1 in Part IX of the Drug Tariff of a 35 per cent. price reduction in continence products. 
Mr. Lansley: To ask the Secretary of State for Health what the benefits and risks are which are being considered as part of the decision to change arrangements for the seasonal influenza programme, as referred to in his letter to the hon. Member for South Cambridgeshire, reference PO00000237366. 
Dawn Primarolo: The Review provided options for fundamentally changing the current system for the purchase and supply of vaccine without incurring additional costs and maintaining the cooperation of providers and general practice.
The current flu vaccination programme has proved successful, and consideration needs to be given to the potential adverse impact that any changes may have on vaccination uptake levels, or confidence of stakeholders in the programme, as well as the potential benefits of a more robust or cost-effective delivery of the programme.
No decision can be taken to change these arrangements until a thorough assessment of the benefits and risks is completed and the results of the 2008-09 programme including the impact of improved information, planning and communication on uptake is known.
To ask the Secretary of State for Health what arrangements he has put in place to ensure that
the UKs stockpile of antivirals can be distributed to the population within the window of therapeutic opportunity. 
Dawn Primarolo: The National Flu Line Service is being set up to enable rapid access to antiviral medicines treatment to those that require it. Arrangements are being made to support this, including the identification of local collection points where antivirals can be collected on behalf of the symptomatic patient (on being authorised treatment via the Flu Line Service). Communications are also being prepared to encourage patients to contact the Flu Line Service within the window of therapeutic opportunity.
Mr. Lansley: To ask the Secretary of State for Health whether he plans to introduce screening for pandemic influenza infection at points of national border entry or exit in the event of an influenza pandemic; and if he will make a statement. 
Dawn Primarolo: Based on available health evidence about their likely effectiveness, there are no plans to impose either entry or exit screening in the United Kingdom in the event of an influenza pandemic. But if such screening were recommended by the World Health Organization, or other countries impose requirements of this nature, we would need to consider our position on a case-by-case basis.
|Next Section||Index||Home Page|